National Health Investors Stock Total Asset
| NHI Stock | USD 65.83 0.19 0.29% |
National Health Investors fundamentals help investors to digest information that contributes to National Health's financial success or failures. It also enables traders to predict the movement of National Stock. The fundamental analysis module provides a way to measure National Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to National Health stock.
| Last Reported | Projected for Next Year | ||
| Total Assets | 2.5 B | 1.3 B | |
| Intangibles To Total Assets | 0.00 | 0.00 |
National | Total Asset |
National Health Investors Company Total Asset Analysis
National Health's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current National Health Total Asset | 2.49 B |
Most of National Health's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, National Health Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
National Total Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for National Health is extremely important. It helps to project a fair market value of National Stock properly, considering its historical fundamentals such as Total Asset. Since National Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of National Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of National Health's interrelated accounts and indicators.
Click cells to compare fundamentals
National Total Asset Historical Pattern
Today, most investors in National Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various National Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of National Health total asset as a starting point in their analysis.
National Health Total Asset |
| Timeline |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
National Total Assets
Total Assets |
|
Based on the latest financial disclosure, National Health Investors has a Total Asset of 2.49 B. This is 75.81% lower than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The total asset for all United States stocks is 91.55% higher than that of the company.
National Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses National Health's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of National Health could also be used in its relative valuation, which is a method of valuing National Health by comparing valuation metrics of similar companies.National Health is currently under evaluation in total asset category among related companies.
National Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of National Health from analyzing National Health's financial statements. These drivers represent accounts that assess National Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of National Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 3.5B | 3.1B | 2.6B | 2.3B | 2.4B | 2.5B | |
| Enterprise Value | 5.0B | 4.6B | 3.8B | 3.5B | 3.5B | 3.7B |
National Health Institutional Holders
Institutional Holdings refers to the ownership stake in National Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of National Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing National Health's value.| Shares | Lasalle Investment Management Securities Llc | 2023-12-31 | 468.5 K | Norges Bank | 2023-12-31 | 455.7 K | Land & Buildings Investment Mgmt, Llc | 2023-12-31 | 412.1 K | Sumitomo Mitsui Trust Holdings Inc | 2024-03-31 | 407.9 K | Waterfront Capital Partners, Llc | 2023-12-31 | 391.5 K | Gw&k Investment Management, Llc | 2023-12-31 | 375.7 K | Legal & General Group Plc | 2023-12-31 | 322.9 K | Goldman Sachs Group Inc | 2023-12-31 | 236.9 K | Jpmorgan Chase & Co | 2023-12-31 | 211.3 K | Vanguard Group Inc | 2023-12-31 | 6.1 M | Blackrock Inc | 2023-12-31 | 4.4 M |
National Fundamentals
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0442 | ||||
| Profit Margin | 0.41 % | ||||
| Operating Margin | 0.63 % | ||||
| Current Valuation | 4.42 B | ||||
| Shares Outstanding | 43.42 M | ||||
| Shares Owned By Insiders | 4.61 % | ||||
| Shares Owned By Institutions | 63.95 % | ||||
| Number Of Shares Shorted | 818.03 K | ||||
| Price To Earning | 13.23 X | ||||
| Price To Book | 2.02 X | ||||
| Price To Sales | 7.92 X | ||||
| Revenue | 319.83 M | ||||
| Gross Profit | 268.98 M | ||||
| EBITDA | 246.88 M | ||||
| Net Income | 134.38 M | ||||
| Cash And Equivalents | 19.29 M | ||||
| Cash Per Share | 0.97 X | ||||
| Total Debt | 1.14 B | ||||
| Debt To Equity | 0.78 % | ||||
| Current Ratio | 2.78 X | ||||
| Book Value Per Share | 33.73 X | ||||
| Cash Flow From Operations | 184.45 M | ||||
| Short Ratio | 5.10 X | ||||
| Earnings Per Share | 3.05 X | ||||
| Price To Earnings To Growth | 1.99 X | ||||
| Target Price | 62.83 | ||||
| Number Of Employees | 26 | ||||
| Beta | 0.98 | ||||
| Market Capitalization | 2.85 B | ||||
| Total Asset | 2.49 B | ||||
| Retained Earnings | 2.47 B | ||||
| Working Capital | 285.14 M | ||||
| Current Asset | 73.06 M | ||||
| Current Liabilities | 52.78 M | ||||
| Annual Yield | 0.05 % | ||||
| Five Year Return | 6.01 % | ||||
| Net Asset | 2.49 B | ||||
| Last Dividend Paid | 3.6 |
About National Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze National Health Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National Health Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
National Health Investors Sentiment
The influence of National Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in National. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to National Health's public news can be used to forecast risks associated with an investment in National. The trend in average sentiment can be used to explain how an investor holding National can time the market purely based on public headlines and social activities around National Health Investors. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
National Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for National Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average National Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on National Health.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards National Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, National Health's short interest history, or implied volatility extrapolated from National Health options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out National Health Piotroski F Score and National Health Altman Z Score analysis. Note that the National Health Investors information on this page should be used as a complementary analysis to other National Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for National Stock analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is National Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 3.05 | Revenue Per Share 7.368 | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.